ArticleJournal of fluorescence2026
Synthesis of 2-(3,5-diarylaminophenyl)-2h-benzo[d][1,2,3]triazoles With Aggregation Induced Emission Properties and Its Applications as a Blue OLED Component.
Article in Journal of fluorescence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, a series of new fluorescent compounds (1a-1e) were synthesized based on 2-phenylbenzotriazole acceptor and various diarylamine donors, and their photophysical properties in different states (solution, film, and powder) were investigated. Emissions of 1a-1e cover the spectrum from 413 nm to 572 nm in toluene solutions with various diarylamino donors on 2-phenylbenzotriazole. Among them, 1d and 1e exhibit the classical AIE properties while 1a, 1b and 1c show good emission in both solution and aggregated states. Additionally, all five compounds present large molar absorptivity (> 30000 L·mol
Indexed as
Identifiers
41746544What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.